TransMedics Group, Inc.
FDA-approved warm perfusion tech and services to increase organ transplant viability and volume.
TMDX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US89377M1099
- LEI:
- Country:
- United States of America
- Address:
- 200 MINUTEMAN ROAD, 1810 ANDOVER
- Website:
- https://www.transmedics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
TransMedics Group, Inc. is a commercial-stage medical technology company focused on transforming organ transplant therapy. The company's flagship product is the Organ Care System (OCS™), a portable platform for the warm perfusion and assessment of donor organs. As the only technology with FDA approval for lung, heart, and liver transplantation in the U.S., the OCS™ is designed to overcome the ischemic time and distance limitations of traditional cold storage. TransMedics also provides the National OCS™ Program (NOP™), an end-to-end service solution combining its technology with clinical expertise to help transplant centers maximize organ utilization, improve clinical outcomes, and increase transplant volumes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all TransMedics Group, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for TransMedics Group, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for TransMedics Group, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
